摘要
本文对肝癌高发区启东肝癌血清中是否存在乙型肝炎病毒Ⅱ型(HBV2)之可能性作了初步研究。结果显示:(1)672例肝癌血清中HBV2感染率为4.02%(2/672),占HBsAg阳性者的5.29%(27/510);(2)HBV1与HBV2混合感染率为1.93%(13/672),占HBsAg阳性者的2.55%(13/510)。说明患者先前感染HBV1后,产生的抗-HBs不能阻止HBV2之再感染,提示将来研制乙肝疫苗时应包括有HBV2之表面抗原。
A study on HBV, infection of sora of primary liver cancer was made in Qidong The total infectional rate of HBV was 95. 39% (641/672). The infectional rate of HBV, was 4. 02% (27/672 ). It cocupied 5.29% (27/510) of the patients with HBaAg positive. The mixed infectional rate of HBV1 and HBV2 was 1. 93(13/672).Although the HBV, was infected ago and the anti-HBs was produced, the anti-HBs was not to prevent the HBV2 infection again. It suggests that the preparation of vaccines must contain the antigen of HBV2 in after.
出处
《肿瘤防治研究》
CAS
CSCD
北大核心
1997年第6期340-341,共2页
Cancer Research on Prevention and Treatment